2026 Clinical Pharmacology Intern (PhD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AbbVie · 2 days ago

2026 Clinical Pharmacology Intern (PhD)

AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Clinical Pharmacology Intern will support the ClinPharm organization by conducting analyses, developing mathematical models, and assisting in clinical study design.

BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Analysis of literature and in-house proprietary data
Dose- and Exposure- Safety & Efficacy Endpoint Analysis
Database Analyses
Development of mathematical models (e.g. PK/PD, Population PK, etc.)
Conducting simulations using mathematical models
Model-Informed Drug Development (MIDD)
Clinical Study Design
Presentation to broader team at the conclusion of the assignment
Publication of authorized analyses

Qualification

PharmacokineticsPharmaceuticsClinical PharmacologyMathematical modelingDatabase analysisLiterature analysisPresentation skills

Required

Currently enrolled in university, pursuing a PharmD or PhD in Pharmacokinetics, Pharmaceutics, Pharmaceutical Sciences, Clinical Pharmacology or other related field
Must be returning to university for at least one semester following the internship

Preferred

Expected graduation date between December 2026 – June 2027

Benefits

Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time

Company

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.

H1B Sponsorship

AbbVie has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)

Funding

Current Stage
Public Company
Total Funding
$15B
2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO

Leadership Team

leader-logo
Robert Michael
Chairman of the Board and Chief Executive Officer
linkedin
leader-logo
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
linkedin
Company data provided by crunchbase